Cargando…
Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration
Major depression brings about a heavy socio-economic burden worldwide due to its high prevalence and the low efficacy of antidepressant drugs, mostly inhibiting the serotonin transporter (SERT). As a result, ~80% of patients show recurrent or chronic depression, resulting in a poor quality of life a...
Autores principales: | Ferrés-Coy, A, Galofré, M, Pilar-Cuéllar, F, Vidal, R, Paz, V, Ruiz-Bronchal, E, Campa, L, Pazos, Á, Caso, J R, Leza, J C, Alvarado, G, Montefeltro, A, Valdizán, E M, Artigas, F, Bortolozzi, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759205/ https://www.ncbi.nlm.nih.gov/pubmed/26100539 http://dx.doi.org/10.1038/mp.2015.80 |
Ejemplares similares
-
RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis
por: Ferrés-Coy, A, et al.
Publicado: (2013) -
Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys
por: Alarcón-Arís, Diana, et al.
Publicado: (2020) -
Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy
por: Miquel-Rio, Lluis, et al.
Publicado: (2022) -
Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice
por: Pavia-Collado, Rubén, et al.
Publicado: (2021) -
Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice
por: Pavia-Collado, Rubén, et al.
Publicado: (2022)